Gregory Tau, MD, PhD

Dr. Gregory Tau in New York City offers Spravato esketamine therapy for patients struggling to find relief from depression. Spravato is an FDA-approved nasal spray for treatment-resistant depression, major depressive disorder, and depression with suicidal thoughts, clinically shown to rapidly decrease symptoms.

Spravato is administered under Dr. Tau's medical supervision in his office, typically two sessions a week for the first month, followed by weekly sessions and then an individualized maintenance schedule.

Triple board-certified in General Psychiatry, Child and Adolescent Psychiatry, and Addiction Medicine, Dr. Tau provides integrated care for children, adolescents, and adults, including evidence-based therapy, advanced medication management, family and parenting support, and treatment for substance use, with medication-assisted options such as Suboxone and Vivitrol available in office.